PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Clinical Pharmacology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.\', \'Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.\', \'Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.\', \'Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.\', \'Division of Health Sciences Informatics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/cts.12919
?:hasPublicationType
?:journal
  • Clinical and translational science
is ?:pmid of
?:pmid
?:pmid
  • 33085221
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.669
?:rankingScore_hIndex
  • 31
?:title
  • Projected Utility of Pharmacogenomic Testing Among Individuals Hospitalized With COVID-19: A Retrospective Multicenter Study in the United States.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all